About: Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 27 October 2008

AttributesValues
rdf:type
description
  • videnskabelig artikel (da)
  • article científic (ca)
  • articolo scientifico (it)
  • artigo científico (pt)
  • bilimsel makale (tr)
  • vedecký článok (sk)
  • vetenskaplig artikel (sv)
  • vědecký článek (cs)
  • wetenschappelijk artikel (nl)
  • wissenschaftlicher Artikel (de)
  • научни чланак (sr)
  • article scientifique (fr)
  • artículu científicu espublizáu en 2008 (ast)
  • наукова стаття, опублікована в жовтні 2008 (uk)
  • مقالة علمية نشرت في 27 أكتوبر 2008 (ar)
  • scientific article published on 27 October 2008 (en)
publication date
publication date
language of work or name
language of work or name
cites work
cites work
author name string
author name string
  • Richard S Finn
  • Michael F Press
  • Maria Koehler
  • Zeba Aziz
  • Jose Bines
  • Zanete Zvirbule
  • Michael C Arbushites
  • Steven H Stein
  • Lisa S Williams
  • Stephanie F Guerrera
rdfs:label
  • Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer. (nl)
  • Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer (en)
  • Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer (ast)
skos:prefLabel
  • Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer. (nl)
  • Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer (en)
  • Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer (ast)
name
  • Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer. (nl)
  • Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer (en)
  • Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer (ast)
author
author
title
title
  • Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer (en)
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software